Ticker Details
Adaptive Biotechnologies Corporation
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.69 | 3.74%
Avg Daily Range (30 D):	$0.77 | 3.33%
Avg Daily Range (90 D):	$0.65 | 3.44%

Institutional Daily Volume
Avg Daily Volume:	1.17M
Avg Daily Volume (30 D):	2.14M
Avg Daily Volume (90 D):	2.13M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	3,319
Avg Institutional Trade:	$2.08M
Avg Institutional Trade (30 D):	$3.35M
Avg Institutional Trade (90 D):	$2.83M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.72M
Avg Closing Trade (30 D):	$7.26M
Avg Closing Trade (90 D):	$6.12M
Avg Closing Volume:	163.02K

News

Jul 12, 2026 @ 9:38 PM An Adaptive Biotechnologies Insider Sold $8.5 Mill... Source: Jonathan Ponciano

Jun 17, 2026 @ 5:21 PM Adaptive Biotechnologies Business Separation May U... Source: Vandana Singh

Jun 17, 2026 @ 10:00 AM Adaptive Biotechnologies Corporation Prices Upsize... Source: Na

Jun 16, 2026 @ 2:42 PM Adaptive Biotechnologies Stock Rises On Plan To Sp... Source: Vandana Singh

Jun 16, 2026 @ 12:49 PM Stock Market Today: S&P 500, Nasdaq Futures Fall, ... Source: Rishabh Mishra

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.41	$-.25	$-.13
Diluted EPS	$-.41	$-.25	$-.13
Revenue	$308.08M	$71.55M	$70.87M
Gross Profit	$232.83M	$51.39M	$52.17M
Net Income / Loss	$-63.99M	$-39.94M	$-20.02M
Operating Income / Loss	$-37.46M	$-15.77M	$-19.21M
Cost of Revenue	$75.25M	$20.17M	$18.71M
Net Cash Flow	$126.72M	$92.31M	$7.11M
PE Ratio